EBV causes
Burrkett’s leukemia/lymphoma
HTLV1 causes
Adult T cell leukemia
Pulmonary leukostasis is more common in
AML
Coagulopathy is common in which AML?
AML M5 + AML M3
RES infiltration is common in
ALL
Gum hypertrophy is common in
AML M5
Sweet’s syndrome and chloroma
AML
Myeloblast
Lymphoblast
Neutrophil primary granules are stained in?
Myeloperoxidase (MPO) (myeloblasts strong +ve, monoblasts faint +ve)
Phospholipids are stained in?
Sudan black B (SBB)
Cellular enzymes are stained in ?
Specific esterase (myeloblasts strong +ve)
M2 , M3 ,M4eo
Favorable prognosis
M0, M1, M5, M6, M7
Unfavorable prognosis
t(8,21), t(15,17), inv(16), normal CG
Favorable prognosis
t(9,22), -5, -7, +8. Complex CG
Unfavorable prognosis
Adverse prognostic factors in ALL: ( high risk)
t(9,22).
t(4,11).
trisomy 8.
Hypodiploidy
Postremission therapy aimed at destroying clinically occult disease.
Remission consolidation (intensification) therapy
Low dose of chemotherapy aimed at preventing the reemergence of leukemia.
Maintenance (continuation) therapy
Initial chemotherapy treatment aimed at achieving a complete remission.
Remission induction therapy
Complete remission of leukemia
■ Disappearance of leukemia after treatment with full regeneration of normal hematopoiesis.
■ <5% blasts in a normocellular bone marrow.
■ Return of peripheral blood count to normal:
■ Neutrophils count > 1500/µL. ■ Platelets count >100,000/µL. ■ hemoglobin level >10 gm/dL.
■ Disappearance of sings and symptoms.
Persistent leukemia, not detectable by light microscopy.
Minimal residual disease
Leukemia that does not enter CR.
Refractory Leukemia
WBC> 100 000
AML